SHARON CRAFT: Open Payments
NPI 1760693089 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,119 in 82 payments from 13 companies in 2025. Trend: 2023 $2,150 · 2024 $2,509 · 2025 $2,119
Food & beverage: $2,119
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $532 |
| Axsome Therapeutics, Inc. | 4 | $291 |
| ABBVIE INC. | 19 | $240 |
| Janssen Pharmaceuticals, Inc | 4 | $190 |
| E.R. Squibb & Sons, L.L.C. | 8 | $170 |
| Neurocrine BioSciences, Inc. | 3 | $156 |
| Alkermes, Inc. | 8 | $152 |
| Otsuka America Pharmaceutical, Inc. | 8 | $149 |
| Supernus Pharmaceuticals, Inc. | 9 | $137 |
| Lundbeck LLC | 2 | $45 |
Products named: CAPLYTA, Auvelity, VRAYLAR, REXULTI, COBENFY, INGREZZA, ARISTADA, Qelbree.
Industry payments across VA — which companies pay providers there.
